Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1Phase 1 1

Status

Terminated 7Completed 5Withdrawn 1Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 4NIH 1

Study Type

Interventional 5

Sponsor

Cancer Type

CNS 3Other neoplasm 1Genitourinary 1Dermatologic 1

Conditions

Neurofibromatosis 1 3Prostatic Neoplasms 1Precancerous Conditions 1Melanoma 1Inhibition, Psychological 1Autism Spectrum Disorder 1

Interventions

Cyclophosphamide 1492Cisplatin 1414Paclitaxel 1317Radiotherapy 1261Carboplatin 1250Gemcitabine 1215Docetaxel 1109Bevacizumab 1030Fluorouracil 894Doxorubicin 792Dexamethasone 748Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 680Etoposide 678Irinotecan 634Filgrastim 621Cytarabine 586Leucovorin 579Nivolumab 558Vincristine 515Prednisone 475Cetuximab 465Bortezomib 459Erlotinib Hydrochloride 456Trastuzumab 447Methotrexate 438Lenalidomide 427Pemetrexed 420

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Interventional × Lovastatin × Clear all
NCT03826940 2021-04-02

ASD/NF1inhib

University of Coimbra

Phase NA Completed
16 enrolled
CNS

Autism Spectrum Disorder, Inhibition, Psychological, Neurofibromatosis 1

NCT00853580 2018-03-12

STARS

University of Alabama at Birmingham

Phase 2 Completed
146 enrolled 29 charts
CNS

Neurofibromatosis 1

NCT00352599 2016-11-22

NF1

University of California, Los Angeles

Phase 1 Completed
44 enrolled
CNS

Neurofibromatosis 1

NCT00580970 2016-11-18

Study of Effectiveness of Lovastatin to Prevent Radiation-Induced Rectal Injury

Virginia Commonwealth University

Phase 2 Completed
73 enrolled 7 charts
Genitourinary

Prostatic Neoplasms

NCT00462280 2014-10-31

Lovastatin in Treating Patients At High Risk of Melanoma

National Cancer Institute (NCI)

Phase 2 Completed
80 enrolled 35 charts
DermatologicOther neoplasm

Melanoma, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡